A Medical Device Daily
Zyvex (Richardson, Texas), a molecular nanotechnology company specializing in micro and nanomanufacturing, micro-electromechanical systems (MEMS), and nanomaterials, has selected Diabetech (Dallas) as its medical device development and commercialization partner for a wireless sensor implant targeting real-time blood glucose levels in the body.
Diabetech provides the capability and patented technologies necessary to develop the patient s hand-held device for not only displaying the glucose levels from the implant to the patient but also for automatically relaying that information in real time to GlucoDynamix, Diabetech s clinical management system.
Diabetech also will be responsible for commercializing this technology as part of its Virtual-Loop Program.
The collaboration is called Project GeNI, which stands for Glucose Nanobiosensor Implant.